Indications of gemcitabine:
- Non-small cell lung cancer (NSCLC)
- Pancreatic cancer
- Breast cancer
- Ovarian cancer
- Bladder cancer
- May also be used in other cancers as recommended by the oncologist.
Administration:
- Supplied as a powder for solution that must be reconstituted with sterile saline.
- Given by intravenous infusion (usually over 30 minutes) in a hospital setting.
- The dosage is based on body surface area, type of cancer, and specific treatment regimen.
- Typically administered in cycles, with rest periods between treatments.
Safety Information:
- Contraindicated in patients with severe bone marrow suppression or known hypersensitivity to gemcitabine.
- Inform your doctor if you have liver or kidney problems, prior chemotherapy, or recent radiotherapy.
- Common side effects: nausea, vomiting, fatigue, fever, rash, mild hair loss, flu-like symptoms.
- Serious risks: bone marrow suppression (low blood counts), infections, bleeding, liver toxicity, kidney impairment, or lung complications (breathing difficulties).
- Regular monitoring of blood counts, liver, and kidney function is required during treatment.
Notice:
Gemcitabine 1g Vial is a prescription-only chemotherapy medicine. It must only be prepared and administered by qualified oncology healthcare professionals in a hospital or specialized cancer treatment center.
Reviews
There are no reviews yet.